Skip to main content
Signal8

Berger Heather A.

SEC insider (Form 3/4/5 filer). CIK 0001751873. Director at Design Therapeutics, Inc. (DSGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CARLSBAD, CA.

Companies Berger Heather A. has filed insider reports for

  • Design Therapeutics, Inc. (DSGN): Director
Berger Heather A. profile photo

Berger Heather A.

CIK: 0001751873

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Design Therapeutics, Inc. logo
DSGN

Design Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jun 9, 2026
    Award

    Stock Option (right to buy)

    Direct
    30K shares-
  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jun 10, 2025
    Award

    Stock Option (right to buy)

    Direct
    19K shares-

1-2 of 2